Chemical Compound
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-(methyl-d3)-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide potassium salt; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidine-4-carboxamide potassium salt; N-(4-Fluorobenzyl)-5-hydroxy-1-(methyl-d3)-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide potassium salt; Raltegravir-d3 potassium; Raltegravir-D3 potassium (N-methyl-D3)
CAS Registry Number
1246816-98-7
Primary record
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-(methyl-d3)-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide potassium salt; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidine-4-carboxamide potassium salt; N-(4-Fluorobenzyl)-5-hydroxy-1-(methyl-d3)-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide potassium salt; Raltegravir-d3 potassium; Raltegravir-D3 potassium (N-methyl-D3)
- 库存
- 4,463 克
- 纯度
- 98.8 %
- CAS
- 1246816-98-7
化合物标识与属性
- CAS
- 1246816-98-7
- PubChem CID
- 46782845
- SMILES
- [2H]C([2H])([2H])N1C(=O)C(=C(N=C1C(C)(C)NC(=O)C2=NN=C(O2)C)C(=O)NCC3=CC=C(C=C3)F)[O-].[K+]
- Canonical SMILES
- [2H]C([2H])([2H])n1c(C(C)(C)NC(=O)c2nnc(C)o2)nc(C(=O)NCc2ccc(F)cc2)c([O-])c1=O.[K+]
名称与同义词
- Raltegravir-d3 Potassium Salt
- Raltegravir-d3, Potassium Salt
- C20H20FKN6O5
- CTK8G2888
- Raltegravir-[d3] Potassium Salt
- IFUKBHBISRAZTF-NXIGQQGZSA-M
- Raltegravir-d3 Potassium (>90%)
- 1246816-98-7
- AKOS030228791
- BLP-013640
- N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide-d3 Potassium Salt
- 871038-72-1
- N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-(methyl-d3)-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide potassium salt; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidine-4-carboxamide potassium salt; N-(4-Fluorobenzyl)-5-hydroxy-1-(methyl-d3)-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide potassium salt; Raltegravir-d3 potassium; Raltegravir-D3 potassium (N-methyl-D3)
- N/A
- potassium;4-[(4-fluorophenyl)methylcarbamoyl]-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]ethyl]-6-oxo-1-(trideuteriomethyl)pyrimidin-5-olate
- potassium;4-[(4-fluorophenyl)methylcarbamoyl]-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxo-1-(trideuteriomethyl)pyrimidin-5-olate